The Windsor Framework proposal to simplify obtaining SPCs from the UK IPO
Read more >
Featured Insights: Biotechnology & Pharmaceuticals
DRUGS VS MEDICAL DEVICES – Imbalances in European IP protection
Read more >
Digital Health: IP at the interface of healthcare and digital technology
Read more >
Wired Health 2022 – Women’s Health Tech Takes Centre Stage
Read more >
The Unitary Patent and UPC – What will it mean for the pharmaceutical sector?
Read more >
Patent Protection for COVID-19-related Innovations
Read more >
International Women’s Day – Female scientists tackling the pandemic
Read more >
International Women’s Day – MIND THE GAP: Closing the gender gaps in life scie...
Read more >
RADIOTHERAPY: The Patent Landscape
Read more >
Sustainable Future: Exploring innovations for the Energy Transition and Circular Economy
Read more >
The Plausibility Saga Continues: Post-filed evidence at the EPO
Read more >
The Drug Exclusivity Landscape in Europe
Read more >
Brazil, it’s just like watching Brazil
Read more >
Patenting MedTech Simulations
Read more >
COVID-19 and the Rapid Rise of Genetic Sequencing
Read more >
Supplementary Protection Certificates (SPCs): Could the EU/UK trade deal have an impact o...
Read more >
China’s new patent law – important changes for the pharmaceutical sector
Read more >
Supplementary Protection Certificates (SPCs): How will the border solution between Irelan...
Read more >
Regeneron v Kymab – Principles capable of general application
Read more >
Seeing Article 3(d) with 2020 vision – revisited
Read more >